Premium
Relationship between sputum clusterin levels and childhood asthma
Author(s) -
Sol I. S.,
Kim Y. H.,
Park Y. A.,
Lee K. E.,
Hong J. Y.,
Kim M. N.,
Kim Y. S.,
Oh M. S.,
Yoon S. H.,
Kim M. J.,
Kim K. W.,
Sohn M. H.,
Kim K. E.
Publication year - 2016
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/cea.12686
Subject(s) - clusterin , asthma , medicine , sputum , methacholine , exacerbation , immunology , bronchial hyperresponsiveness , spirometry , eosinophil , pulmonary function testing , biomarker , bronchiolitis , gastroenterology , respiratory disease , pathology , lung , respiratory system , tuberculosis , biology , apoptosis , biochemistry
Summary Background Clusterin is a sensitive cellular biosensor of oxidative stress and has been studied as a biomarker for inflammation‐associated diseases. Clusterin levels in childhood asthma have not been evaluated. Objectives (1) To evaluate sputum clusterin levels in children with asthma compared to a control group. (2) To assess the relationships between sputum clusterin levels and airway inflammation, pulmonary function, and bronchial hyperresponsiveness. Methods This study included 170 children aged 5–18 years with stable asthma ( n = 91), asthma exacerbation ( n = 29), or no asthma (healthy controls; n = 50). Induced sputum, pulmonary function, and methacholine challenge tests were performed. Stable asthma was classified into two groups according to the severity. Clusterin levels in sputum were measured using an enzyme‐linked immunosorbent assay. Results Children with stable asthma had a higher clusterin level than healthy controls [4540 (3872–5651) pg/mL vs. 3857 (1054–4369) pg/mL, P < 0.001]. The clusterin level was also more elevated in eosinophil‐dominant sputum than in non‐eosinophilic sputum in stable asthma [5094 (4243–6257) pg/mL vs. 4110 (1871–4839) pg/mL, P = 0.0017]. Clusterin levels were associated with asthma severity. Paradoxically, clusterin levels were lower during asthma exacerbation than in stable asthma [1838 (350–4790] pg/mL vs. 4540 (3872–5651) pg/mL, P < 0.001]. Clusterin levels were strongly correlated with the methacholine concentration that caused a 20% decrease in the forced expiratory volume in 1 s ( r = −0.617, P < 0.001); there was no significant correlation between clusterin levels and other pulmonary function parameters. Conclusions and Clinical Relevance Clusterin levels were altered in children with stable asthma and asthma exacerbation because of its antioxidant and anti‐inflammatory effects. Clusterin may be a marker that reflects airway inflammation and severity of symptoms, and it can be used in the assessment and management of childhood asthma.